This is in disagreement with a previous study that demonstrated that high GPER expression was associated with adverse relapse free survival of breast cancer patients treated with tamoxifen but did not describe associations with breast cancer specific survival [17]. The gene discussed is GPER1; the disease is breast carcinoma.